These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Chen G; Waxman DJ Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907 [TBL] [Abstract][Full Text] [Related]
65. Potential alkylating agents derived from benzimidazole and benzothiazole. Omar AM; Habib NS; Aboulwafa OM J Pharm Sci; 1982 Sep; 71(9):991-3. PubMed ID: 7131285 [No Abstract] [Full Text] [Related]
66. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds. Hano K; Akashi A Gan; 1965 Aug; 56(4):377-84. PubMed ID: 4954024 [No Abstract] [Full Text] [Related]
67. ALKYLATION OF SYNTHETIC POLYNUCLEOTIDES. LUDLUM DB; WARNER RC; WAHBA AJ Science; 1964 Jul; 145(3630):397-9. PubMed ID: 14172601 [TBL] [Abstract][Full Text] [Related]
68. [Interaction of alkylating oligonucleotide derivatives with mammalian cells. A study of the uptake mechanism of derivative cells]. Vlasov VV; Ivanova EM; Kutiavin IV; Raĭt AS; Iurchenko LV Mol Biol (Mosk); 1989; 23(1):93-100. PubMed ID: 2739651 [TBL] [Abstract][Full Text] [Related]
69. [Cytostatic agents and male fertility]. Wildschut J; den Ottolander GJ; Hartgrink-Groeneveld CA Ned Tijdschr Geneeskd; 1976 Mar; 120(10):412-7. PubMed ID: 1250434 [No Abstract] [Full Text] [Related]
70. Studies with alkylating esters. VI. The chemical and biological activities of the isomers of dimethylmyleran. Jones AR Chem Biol Interact; 1973 Jan; 6(1):47-57. PubMed ID: 4689909 [No Abstract] [Full Text] [Related]
72. Effect of alkylating antitumor agents on the binding of DNA to protein. Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930 [No Abstract] [Full Text] [Related]
73. Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems. Perez RP; Hamilton TC; Ozols RF Pharmacol Ther; 1990; 48(1):19-27. PubMed ID: 2274575 [TBL] [Abstract][Full Text] [Related]
74. Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents. Tanasova M; Sturla SJ Chem Rev; 2012 Jun; 112(6):3578-610. PubMed ID: 22482429 [No Abstract] [Full Text] [Related]
75. 2- and 6-methyl-1,4-naphthoquinone derivatives and potential bioreductive alkylating agents. Antonini I; Lin TS; Cosby LA; Dai YR; Sartorelli AC J Med Chem; 1982 Jun; 25(6):730-5. PubMed ID: 7097727 [TBL] [Abstract][Full Text] [Related]
76. Induction of chromosomal aberrations and mutations with isomeric forms of L-threitol-I,4-bismethanesulfonate in plant materials. Matagne R Mutat Res; 1969; 7(2):241-7. PubMed ID: 5796521 [No Abstract] [Full Text] [Related]
77. The anesthetic implications of chemotherapy. Ciresi SA AANA J; 1983 Feb; 51(1):26-30. PubMed ID: 6858573 [No Abstract] [Full Text] [Related]
78. Pharmacology and toxicology of chemotherapeutic agents. Rodrigues RL Emerg Med Clin North Am; 1993 May; 11(2):431-43. PubMed ID: 8491115 [TBL] [Abstract][Full Text] [Related]
79. Alkylating agents, nitrosoureas and alkyltriazenes. Connors TA Cancer Chemother Biol Response Modif; 1987; 9():23-35. PubMed ID: 3079405 [No Abstract] [Full Text] [Related]
80. [Mixed, Yoshida-type tumors, resistant and sensitive to alkylating agents]. Winkler A; Ujházy V; Sándor L; Drahovský D Cas Lek Cesk; 1966 Sep; 105(39):1068-71. PubMed ID: 5976461 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]